Miso Clinic · Clinical column

ONDA lifting vs Density · XERF in Daegu: how do they differ?

If you look up “ONDA lifting Daegu,” it appears side by side with Density · XERF and looks like the same family. They are devices that differ from the very type of energy. I have written what is heated where, and how far human data goes.

Clinical column About 7 min September 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

ONDA lifting is a microwave device; Density and XERF are RF devices. The layers mainly heated differ. ONDA uses 2.45 GHz microwaves, a frequency well absorbed by fat. So manufacturer material and published studies are mostly concentrated on areas with fat — abdomen · thighs · under the chin. Density (Jeisys Medical) and XERF (Lutronic) are RF, heating the dermis and the fibrous septa below it. So the question is not “which is better” but “is what has descended in my face fat, or firmness?” We found no study comparing the three devices side by side in one trial. Miso Clinic has Density, XERF and Oligio Kiss, and does not have ONDA. So this piece goes only as far as “what each device heats,” not “which device is better.” Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Different energy heats different layers

All three are devices that tighten tissue with heat. But depending on the energy used, where that heat is mostly generated differs.

Energy of the three devices and manufacturers’ published material
DeviceEnergyMain target stated by the manufacturer
ONDAMicrowave 2.45 GHz, up to 200 WFat layer — uses the property that microwaves are absorbed by fat
Density (DENSITY)Sequential monopolar → bipolar RF, up to 400 WDermis and subcutis — adjusts output by watching impedance
XERFMonopolar RF 6.78 MHz + 2 MHz6.78 MHz for the fibrous septa, 2 MHz deeper and broader

The manufacturer and papers describe ONDA as acting on fat in the same direction. But most of that data comes from body areas such as the abdomen · thighs, not from whole-face lifting. There is also data that XERF’s 2 MHz produces broad heat in the fat layer, but that is from pig tissue and computer simulation, so it is hard to carry over directly to the human face.

So what do we look at, in which case?

What we look at first in consultation is not the device name but what has descended in the face. We don’t approach someone with a heavy area under the chin and someone whose cheeks have thinned and hollowed with the same device.

Depending on what has descended (Miso Clinic clinical judgement)
State of the faceDirection we look at first
Fat sits plumply under the chin · along the lower jawReducing fat may need to come first — this is where devices targeting the fat layer, like ONDA, are discussed
Not much fat, but skin sags and lacks firmnessRF that tightens the dermis · fibrous septa — this is where Density · XERF sit
Cheeks look thin and hollowWe avoid reducing fat with heat — we look first at volume and collagen
Sagging and thinning togetherWe don’t try to solve everything with one device; we set an order

Putting fat-targeting energy into a face with little fat can go in the opposite direction from what you want. There is a 200-person ultrasound review in which sagging submental areas had thinner skin and thicker superficial fat (Kwon 2022). It means even the same “sagging” has a different make-up by area, so we don’t use the same setting over the whole face. Why we look at skin thickness and fat is written in Lifting in Daegu: why we look at skin thickness and fat.

How far does human data go for each?

None of the three devices has a comparative trial with a control group. I’ll just note the scale and observation period. A larger number doesn’t mean thicker evidence.

Published human data (as of September 2026)
DeviceKey dataLimitations
ONDA10 women with submental laxity · 2 sessions 30 days apart · 10 min per session · assessed at 12 weeks; laxity scale mean 3.6 → 2.3 (Zappia 2025)10 people · no control group · submental area, not the whole face
Density (DENSITY)16 Japanese patients · one session · 24 weeks, tightening 0.82 mm · lower-face thickness −0.89 mm (Oku 2025)16 people · no control group · single author
XERFThree studies of 20 · 39 · 16 people, 12 weeks to 3 monthsNone of the three had a control group · one manufacturer-supported

Head-to-head device trials are almost absent from this whole field. A 2026 systematic review of RF devices (15 studies · 1,230 people) also stated in its text that no head-to-head device comparisons were found. We also found no data putting ONDA and Density, or ONDA and XERF, in one trial. So statements like “ONDA is better than Density” have no evidence in either direction.

30,000 J and 600 shots are not the same unit

This is where people get stuck most when comparing prices. ONDA counts dose as total energy, in joules (J). The “J” in “30,000 J · 60,000 J” is joules, not lines. This is because it delivers continuously over a set time rather than firing shots one by one. The submental study above also states it used 35,000–45,000 J in 10 minutes per session.

Density and XERF count in shots. The number of shots sealed in the tip is fixed, so you get numbers like “600 shots.” There is no conversion formula between the two units — neither in manufacturer material nor in papers.

Why the units are mixed like this, and why the same 600 shots isn’t the same amount, is written separately in Can 600 shots and 30,000 J be compared?.

Ask this at consultation

  • “Is my face’s problem fat, or firmness?” — this answer decides the device. The reverse order won’t do.
  • “Which layer does this device heat?” — you should get an answer: fat layer or dermis.
  • “What is the dose counted in?” — you need to know whether shots, joules (J) or time to compare quotes.
  • “My cheeks tend to look hollow — is that OK?” — a question to raise if your face is thin.
  • “Can I check the product approval number?” — how to is in How to look up an approval number yourself.

Miso Clinic has Density · XERF · Oligio Kiss and looks at the face first, then decides the device. How we divide the three devices is written in Choosing Oligio Kiss · Density · XERF in Daegu. Fees vary by area and extent, so we give them by phone or at an in-person consultation. Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

In summary — what is established and what is not

Established

  • ONDA is a 2.45 GHz microwave device, and this frequency is well absorbed by fat
  • Density · XERF are RF devices and heat the dermis · fibrous septa
  • ONDA counts dose in joules (J); Density · XERF count in shots
  • Published human data for all three devices lack control groups

Not established

  • Data comparing ONDA and Density · XERF side by side in one trial
  • Large human data on ONDA for whole-face lifting — what has been published is 10 submental patients and body data

ONDA lifting vs Density · XERF in Daegu: frequently asked questions

How do ONDA lifting and Density differ?

ONDA lifting is a device using 2.45 GHz microwaves, and Density is an RF device. Microwaves are well absorbed by fat so heat is generated mostly in the fat layer, while RF heats the dermis and the fibrous septa below it. Because the energy type differs, they are hard to compare as the same family.

Which is better, ONDA lifting or XERF?

We found no data comparing the two devices side by side in one trial. The direction differs depending on whether fat sits plumply in the face or there isn’t much fat but firmness is lacking. It is right to decide the facial condition before the device name.

What does “30,000 J” mean for ONDA lifting?

ONDA’s “J” is joules, not lines — total energy. ONDA delivers continuously over a set time rather than firing shots one by one, so it totals the energy delivered. A published submental study used 35,000–45,000 J in 10 minutes per session.

Does ONDA lifting reduce facial fat?

ONDA’s published data is typified by waist reduction in 12 abdominal patients and laxity improvement in 10 submental patients, both without control groups. Areas with plump fat and thin areas can respond differently, so for those whose cheeks look thin and hollow, we don’t recommend a fat-targeting approach.

Does Miso Clinic have ONDA?

Miso Clinic does not have ONDA. We have Density, XERF and Oligio Kiss. This column is not meant to rank devices, but to set out how their energy and targets differ.

Density and XERF are both RF, so why use them separately?

Density delivers monopolar and bipolar in sequence, and XERF uses monopolar with two frequencies, 6.78 MHz and 2 MHz. The choice depends on skin thickness, fat amount and sagging area, so Miso Clinic decides by looking at the face.

Why is there no study comparing the three devices?

A 2026 systematic review of RF devices (15 studies, 1,230 people) also stated in its text that no head-to-head device comparisons were found. Comparative trials with control groups are rare across the whole field of aesthetic devices.

Where can I get a lifting consultation in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station, +82-53-428-2700. Open weekdays 11:00–19:00 and Saturday 10:00–16:00; closed Sundays and public holidays.

Clinical columns to read next

Product reference

Product references: Density · XERF · Oligio Kiss · device specs compared: Density · XERF · Oligio specs compared

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. ONDA specifications — DEKA (Florence, Italy) published material: microwave 2.45 GHz, manufacturer name Coolwaves, maximum output 200 W, with epidermal cooling, handpieces Deep · Shallow · Pocket. Dose is counted in total energy (J) and time, not shots. Miso Clinic does not have ONDA.
  2. ONDA submental human study — Zappia E et al., Lasers Med Sci 2025;40(1):28, PMID 39841282. 10 women (mean age 56.3 ± 6.6) · Pocket handpiece · 2 sessions 30 days apart · 10 minutes per session · 35,000–45,000 J per session (70–90 W) · assessed 12 weeks after the last session. Submental laxity scale mean 3.6 → 2.3, no adverse events reported. No control group, 10 people, and submental rather than whole-face data.
  3. ONDA body data — reported median abdominal circumference reduction of 3.90 cm after 4 sessions in 12 people with localised abdominal fat; international advisory panel recommendations on cellulite · localised fat (J Clin Med 2024, PMC11672876). This is body data and cannot be carried over directly as evidence for facial lifting.
  4. Density specifications — Jeisys Medical published material: sequential monopolar → bipolar delivery, up to 400 W, RIC automatic impedance adjustment, 5-level gas cooling, real-time skin temperature, tips ALPHA 600 · Eye 600 · Face 1,000 · Body 600 shots (guaranteed shot counts). An MFDS-approved medical device.
  5. XERF specifications — Lutronic published material: monopolar, 6.78 MHz + 2 MHz, handpieces i05 (5×10 mm · 400 shots) · i10 (10×10 mm · 300 shots) · E40 (20×20 mm · 600 shots) · E60 (20×30 mm · 600 shots). Shot counts are guaranteed counts sealed in the tip, not recommended values for how many shots to use on a face. Korean approval classification: general-purpose electrosurgical unit; advertising review “General-purpose electrosurgical unit association-2024-16-054”.
  6. Human data on Density — Oku K, J Cosmet Dermatol 2025;24(10):e70504, PMID 41090512. 16 Japanese patients (1 man · 15 women, mean age 49.4 ± 6.1) · about 500–600 shots per session · 24 weeks · no control group · single author. Tightening 0.82 mm, lower-face thickness −0.89 mm, GAIS improved in 15 of 16, pain 1.4/5.
  7. Three human studies of XERF — Hwang JK, Medical Lasers 2025;14(1):23–30 (20 people · one session · 12 weeks) · Weiss RA et al., Cureus 2026;18(3):e104546, PMID 41930066 (39 people · two sessions · 90 days, manufacturer-supported) · Erlich G et al., Lasers Med Sci 2026;41(1), PMID 42611100 (retrospective 16 people · one session · 3 months). None of the three had a control group.
  8. Evidence comparing devices — Aesthetic Surgery Journal Open Forum 2026 systematic review (15 studies · 1,230 people, 1 randomised controlled trial). States that no head-to-head device comparisons were found. We also found no data comparing ONDA and Density, or ONDA and XERF, side by side in one trial.
  9. Heating by XERF frequency — Ko K et al., Lasers Med Sci 2025, PMID 41315066. Computer simulation · pig tissue. 2 MHz heats broadly and deeply in the fat layer; 6.78 MHz heats locally along the fibrous septa. Many authors are manufacturer-affiliated, and it is not a human study.
  10. Ultrasound of lower-face layer structure — Kwon SH et al., Dermatologic Surgery 2022;48(5):527–531, PMID 35093961. Retrospective review of 200 people. Sagging submental areas had thinner skin and thicker superficial fat.
  11. Medical advertising law — Korean Medical Service Act Article 56(2). Prohibits treatment-testimonial advertising, comparison with other clinics and superlatives. This is why this column states only device principles and data and does not rank them.
  12. Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語